Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
In the February 6, 2015, Federal Register, FDA reopened the docket to solicit public comment on certain topics related to implementation of the Generic Drug User Fee Amendments of 2012...
United StatesFood, Drugs, Healthcare, Life Sciences
In the February 6, 2015, Federal Register,
FDA reopened the docket to solicit public comment on certain topics
related to implementation of the Generic Drug User Fee Amendments
of 2012 ("GDUFA") and the GDUFA Commitment Letter that
accompanies the legislation. Comments due March 9,
2015.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.